Improvements when switching Freelite assays from Roche cobas 8000 to Optilite analyzer

5 Mar 2026

Clinical laboratories managing serum-free light chain (sFLC) testing often face pressure to reduce turnaround times, minimize manual interventions, and control reagent use. This case study explores the impact of moving Freelite® assays from the Roche cobas™ 8000 to the Optilite® analyzer, assessing 306 routine specimens and 48 elevated FLC samples. The results demonstrate faster workflows, meaningful reagent savings, and the complete removal of manual dilutions to streamline sFLC testing while reducing error‑prone steps.

Optilite® Freelite® Assays

Binding Site

Detect and monitor Multiple Myeloma (MM) with Freelite® assays. The time-tested and proven solution for kappa and lambda serum free light chain (sFLC) analysis

(0)

Links

Tags